Neumora Therapeutics, Inc.
NMRA
$1.63
$0.010.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 217.59M | 249.35M | 307.58M | 341.31M | 371.64M |
| Total Receivables | -- | -- | -- | -- | 1.63M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.32M | 4.30M | 5.26M | 6.09M | 3.83M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 1.21M | 1.21M | 1.21M | 21.22M |
| Total Current Assets | 222.91M | 254.87M | 314.06M | 348.61M | 398.32M |
|
|
|||||
| Total Current Assets | 222.91M | 254.87M | 314.06M | 348.61M | 398.32M |
| Net Property, Plant & Equipment | 618.00K | 1.88M | 2.92M | 3.93M | 4.94M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 298.00K | -- | -- | -- | 1.21M |
| Total Assets | 223.83M | 256.75M | 316.97M | 352.54M | 404.47M |
|
|
|||||
| Total Accounts Payable | 644.00K | 1.05M | 3.31M | 6.11M | 1.08M |
| Total Accrued Expenses | 20.25M | 26.27M | 24.59M | 22.76M | 18.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 171.00K | 938.00K | 1.85M | 2.75M | 3.61M |
| Total Finance Division Other Current Liabilities | 88.00K | 122.00K | 133.00K | 133.00K | 133.00K |
| Total Other Current Liabilities | 88.00K | 122.00K | 133.00K | 133.00K | 133.00K |
| Total Current Liabilities | 21.16M | 28.38M | 29.89M | 31.74M | 23.13M |
|
|
|||||
| Total Current Liabilities | 21.16M | 28.38M | 29.89M | 31.74M | 23.13M |
| Long-Term Debt | 19.45M | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 339.00K | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 22.00K | 55.00K | 89.00K |
| Total Liabilities | 40.95M | 28.38M | 29.91M | 31.80M | 23.21M |
|
|
|||||
| Common Stock & APIC | 1.25B | 1.24B | 1.23B | 1.21B | 1.20B |
| Retained Earnings | -1.07B | -1.02B | -947.22M | -888.40M | -815.86M |
| Treasury Stock & Other | -15.00K | -3.00K | 62.00K | 105.00K | -187.00K |
| Total Common Equity | 182.88M | 228.36M | 287.06M | 320.74M | 381.26M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 182.88M | 228.36M | 287.06M | 320.74M | 381.26M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 182.88M | 228.36M | 287.06M | 320.74M | 381.26M |
|
|
|||||